BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Obrocki P, Khatun A, Ness D, Senkevich K, Hanrieder J, Capraro F, Mattsson N, Andreasson U, Portelius E, Ashton NJ, Blennow K, Schöll M, Paterson RW, Schott JM, Zetterberg H. Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course-a joint PhD student course at University College London and University of Gothenburg. Alzheimers Res Ther 2020;12:20. [PMID: 32111242 DOI: 10.1186/s13195-020-00586-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Savonenko AV, Wong PC, Li T. Alzheimer diseases. Neurobiology of Brain Disorders 2023. [DOI: 10.1016/b978-0-323-85654-6.00022-8] [Reference Citation Analysis]
2 Ovsepian SV, O'leary VB. Adult Neurogenesis in the Gut, Homeostatic Autoimmunity and Neurodegenerative Disease Biomarkers. Neuroscience 2022;504:75-78. [DOI: 10.1016/j.neuroscience.2022.09.019] [Reference Citation Analysis]
3 Svenningsson AL, Stomrud E, Palmqvist S, Hansson O, Ossenkoppele R. Axonal degeneration and amyloid pathology predict cognitive decline beyond cortical atrophy. Alzheimers Res Ther 2022;14:144. [PMID: 36192766 DOI: 10.1186/s13195-022-01081-w] [Reference Citation Analysis]
4 Tzartos JS, Boufidou F, Stergiou C, Kuhle J, Willemse E, Palaiodimou L, Tsantzali I, Sideri E, Bonakis A, Giannopoulos S, Voumvourakis KI, Tsivgoulis G, Tzartos SJ, Kapaki E, Paraskevas GP. Plasma P-Tau181 for the Discrimination of Alzheimer’s Disease from Other Primary Dementing and/or Movement Disorders. Biomolecules 2022;12:1099. [DOI: 10.3390/biom12081099] [Reference Citation Analysis]
5 Tsantzali I, Foska A, Sideri E, Routsi E, Tsomaka E, Kitsos DK, Zompola C, Bonakis A, Giannopoulos S, Voumvourakis KI, Tsivgoulis G, Paraskevas GP. Plasma Phospho-Tau-181 as a Diagnostic Aid in Alzheimer’s Disease. Biomedicines 2022;10:1879. [DOI: 10.3390/biomedicines10081879] [Reference Citation Analysis]
6 Koníčková D, Menšíková K, Tučková L, Hényková E, Strnad M, Friedecký D, Stejskal D, Matěj R, Kaňovský P. Biomarkers of Neurodegenerative Diseases: Biology, Taxonomy, Clinical Relevance, and Current Research Status. Biomedicines 2022;10:1760. [DOI: 10.3390/biomedicines10071760] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Heimfarth L, Passos FRS, Monteiro BS, Araújo AADS, Quintans Júnior LJ, Quintans JDSS. Serum glial fibrillary acidic protein is a body fluid biomarker: A valuable prognostic for neurological disease – A systematic review. International Immunopharmacology 2022;107:108624. [DOI: 10.1016/j.intimp.2022.108624] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
8 Kocurova G, Ricny J, Ovsepian SV. Autoantibodies targeting neuronal proteins as biomarkers for neurodegenerative diseases. Theranostics 2022;12:3045-56. [PMID: 35547759 DOI: 10.7150/thno.72126] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Bramall AN, Anton ES, Kahle KT, Fecci PE. Navigating the ventricles: Novel insights into the pathogenesis of hydrocephalus. EBioMedicine 2022;78:103931. [PMID: 35306341 DOI: 10.1016/j.ebiom.2022.103931] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Vidal-piñeiro D, Sørensen Ø, Blennow K, Capogna E, Halaas N, Idland A, Mowinckel A, Pereira J, Watne L, Zetterberg H, Walhovd K, Fjell A. Relationship between cerebrospinal fluid neurodegeneration biomarkers and temporal brain atrophy in cognitively healthy older adults. Neurobiology of Aging 2022. [DOI: 10.1016/j.neurobiolaging.2022.04.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Berdowska I, Matusiewicz M, Krzystek-korpacka M. HDL Accessory Proteins in Parkinson’s Disease—Focusing on Clusterin (Apolipoprotein J) in Regard to Its Involvement in Pathology and Diagnostics—A Review. Antioxidants 2022;11:524. [DOI: 10.3390/antiox11030524] [Reference Citation Analysis]
12 Wang X, Li F, Gao Q, Jiang Z, Abudusaimaiti X, Yao J, Zhu H. Evaluation of the Accuracy of Cognitive Screening Tests in Detecting Dementia Associated with Alzheimer's Disease: A Hierarchical Bayesian Latent Class Meta-Analysis. J Alzheimers Dis 2022. [PMID: 35275533 DOI: 10.3233/JAD-215394] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Knorr U, Simonsen AH, Jensen CS, Zetterberg H, Blennow K, Akhøj M, Forman J, Hasselbalch SG, Kessing LV. Alzheimer's disease related biomarkers in bipolar disorder - A longitudinal one-year case-control study. J Affect Disord 2022;297:623-33. [PMID: 34728295 DOI: 10.1016/j.jad.2021.10.074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Wei Y, Liu S, Cai J, Tang X, Zhang J, Xu M, Liu Q, Wei C, Mo X, Huang S, Lin Y, Mai T, Tan D, Luo T, Gou R, Lu H, Qin J, Zhang Z. Associations of TFEB Gene Polymorphisms With Cognitive Function in Rural Chinese Population. Front Aging Neurosci 2021;13:757992. [PMID: 34970136 DOI: 10.3389/fnagi.2021.757992] [Reference Citation Analysis]
15 Carregari VC. Protein Extraction and Sample Preparation Methods for Shotgun Proteomics with Central Nervous System Cells and Brain Tissue. Advances in Experimental Medicine and Biology 2022. [DOI: 10.1007/978-3-031-05460-0_1] [Reference Citation Analysis]
16 Xu MM, Zhou MT, Li SW, Zhen XC, Yang S. Glycoproteins as diagnostic and prognostic biomarkers for neurodegenerative diseases: A glycoproteomic approach. J Neurosci Res 2021;99:1308-24. [PMID: 33634546 DOI: 10.1002/jnr.24805] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
17 Vissers MFJM, Heuberger JAAC, Groeneveld GJ. Targeting for Success: Demonstrating Proof-of-Concept with Mechanistic Early Phase Clinical Pharmacology Studies for Disease-Modification in Neurodegenerative Disorders. Int J Mol Sci 2021;22:1615. [PMID: 33562713 DOI: 10.3390/ijms22041615] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Rastogi S, Sharma V, Bharti PS, Rani K, Modi GP, Nikolajeff F, Kumar S. The Evolving Landscape of Exosomes in Neurodegenerative Diseases: Exosomes Characteristics and a Promising Role in Early Diagnosis. Int J Mol Sci 2021;22:E440. [PMID: 33406804 DOI: 10.3390/ijms22010440] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 41.0] [Reference Citation Analysis]
19 Mishra B, Vishnu VY, Department of Neurology, All India Institute of Medical Sciences, New Delhi, India, Department of Neurology, All India Institute of Medical Sciences, New Delhi, India. Lumbar Puncture: Indications, Challenges and Recent Advances. Neurology 2021;17:23. [DOI: 10.17925/usn.2021.17.1.23] [Reference Citation Analysis]
20 Murti BT, Putri AD, Huang Y, Wei S, Peng C, Yang P. Clinically oriented Alzheimer's biosensors: expanding the horizons towards point-of-care diagnostics and beyond. RSC Adv 2021;11:20403-20422. [DOI: 10.1039/d1ra01553b] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]